Portage Biotech Inc. (NASDAQ:PRTG – Get Rating) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 52,900 shares, a growth of 32.6% from the March 15th total of 39,900 shares. Based on an average daily volume of 35,900 shares, the days-to-cover ratio is […]
Should You Buy or Sell Portage Biotech Stock? Get The Latest PRTG Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.